Beier Drawtex Healthcare is a global wound care company that combines over 80 years of manufacturing intelligence with an ethos to change the face of advanced wound care through unique technologies and clinical excellence.
Drawtex dedicated international team based in South Africa supports their rapidly growing network of strategically chosen and experienced international distributors to ensure clear and consistent marketing and the clinical message is communicated in each market.
Drawtex® is the first hydroconductive wound dressing. It features exclusive LevaFiber™ Technology aiding effective wound bed preparation without damaging newly formed tissue.
Because of its three types of action (capillary, hydroconductive, and electrostatic), made possible by exclusive LevaFiber Technology, Drawtex is more than just a simple absorber. Drawtex can be used as a
first-line dressing as part of the standard of care for wound bed preparation.
The manufacturing of Drawtex is carried out in our state-of-the-art factory and produced under ISO 13485:2016 and CE (European) mark registration, the guarantee of quality products to the highest European Standards and the Food and Drug Administration (FDA) of the United States.